DEF 14A: Definitive information statements
Apr 27 04:51
DEFA14A: Others
Apr 27 04:50
Bionano Genomics | 8-K: Bionano Genomics Filed a Prospectus Supplement
Apr 9 04:58
Bionano Genomics | 424B5: Prospectus
Apr 8 20:47
Bionano Genomics | 8-K: Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Apr 5 21:33
Bionano Genomics | ARS: Annual Report to Security Holders
Mar 7 01:33
Bionano Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Chaubey Alka
Mar 6 06:54
Bionano Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Dixon Jonathan V.
Mar 6 06:50
Bionano Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Holmlin R. Erik
Mar 6 06:50
Bionano Genomics | 4: Statement of changes in beneficial ownership of securities-Officer OLDAKOWSKI MARK
Mar 6 06:49
Bionano Genomics | 10-K: Annual report
Mar 6 06:30
Bionano Genomics | 8-K: Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024
Mar 6 05:29
Bionano Genomics | 8-K: Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway
Feb 28 21:17
Bionano Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.88%)
Feb 14 07:10
Bionano Genomics | 8-K: Bionano Reports Preliminary Fourth Quarter and Full-Year 2023 Results
Jan 8 13:00
Bionano Genomics | 8-K: Current report
Nov 25, 2023 02:05
Bionano Genomics | 424B3: Prospectus
Nov 9, 2023 05:52
Bionano Genomics: Q3 2023 Earnings Report
Nov 9, 2023 05:20
Bionano Genomics | 8-K: Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress
Nov 9, 2023 05:02
Bionano Genomics | EFFECT: Others
Nov 7, 2023 13:15
No Data
No Data